Protara Therapeutics Inc (TARA)

NASDAQ
8.38
-0.35(-4.01%)
  • Volume:
    85,962
  • Bid/Ask:
    8.00/8.85
  • Day's Range:
    8.11 - 8.77

TARA Overview

Prev. Close
8.73
Day's Range
8.11-8.77
Revenue
-
Open
8.77
52 wk Range
8-36.69
EPS
-4.47
Volume
85,962
Market Cap
94.1M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
60,026
P/E Ratio
-
Beta
0.69
1-Year Change
-67.77%
Shares Outstanding
11,228,606
Next Earnings Date
Nov 11, 2021
What is your sentiment on Protara Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

Protara Therapeutics Inc News

Protara Therapeutics Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsBuyStrong BuyStrong SellStrong SellStrong Sell
SummaryNeutralStrong SellStrong SellStrong SellStrong Sell

Protara Therapeutics Inc Company Profile

Protara Therapeutics Inc Company Profile

Employees
27

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company’s lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York.

Read More
  • Please..
    0
    • Uptrending
      0
      • ?
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.